Maxcyte (MXCT) EBITDA Margin (2020 - 2026)
Maxcyte (MXCT) reported EBITDA Margin of 53.41% for Q1 2026, up 14176.0% year-over-year from N/an in Q1 2025, and up 92.13% quarter-over-quarter from 678.42% in Q4 2025.
Maxcyte (MXCT) EBITDA Margin (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has 7 years of EBITDA Margin data on file, last reported at 53.41% in Q1 2026.
- EBITDA Margin for Q1 2026 came in at 53.41%, up 14176.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.53% (up 2117.0% YoY), and the FY2025 annual result was 24.26%, down 1321.0% from the prior year.
- EBITDA Margin climbed to 53.41% in Q1 2026 per MXCT's latest filing, from 678.42% in the prior quarter.
- Over five years, EBITDA Margin peaked at 353.96% in Q4 2024 and troughed at 678.42% in Q4 2025.
- A 5-year average of 148.28% and a median of 170.23% in 2023 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin soared 52419 bps in 2024, then sank 103239 bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 218.48% in 2022, then plunged by 178 bps to 170.23% in 2023, then soared by 308 bps to 353.96% in 2024, then plunged by 292 bps to 678.42% in 2025, then jumped by 92 bps to 53.41% in 2026.
- Business Quant data shows MXCT's EBITDA Margin at 53.41% in Q1 2026, 678.42% in Q4 2025, and 191.71% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Maxcyte | 127.72 Mn | 127.72 Mn | 8.08 Mn | -53.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.41% |
| Dec 31, 2025 | -678.42% |
| Sep 30, 2025 | -191.71% |
| Jun 30, 2025 | -225.58% |
| Mar 31, 2025 | -195.18% |
| Dec 31, 2024 | 353.96% |
| Sep 30, 2024 | -159.08% |
| Jun 30, 2024 | -219.32% |
| Mar 31, 2024 | -219.82% |
| Dec 31, 2023 | -170.23% |
| Sep 30, 2023 | -335.71% |
| Jun 30, 2023 | -144.56% |
| Mar 31, 2023 | -265.47% |
| Dec 31, 2022 | 218.48% |
| Sep 30, 2022 | -107.83% |
| Jun 30, 2022 | -90.96% |
| Mar 31, 2022 | -35.89% |
| Dec 31, 2021 | 228.28% |
| Sep 30, 2021 | -43.56% |
| Jun 30, 2021 | -62.14% |